| ORIGINAL ARTICLE |
|
| Year : 2022 | Volume
: 20
| Issue : 1 | Page : 32-36 |
|
|
Vaccination against COVID-19 among people living with HIV: A cross-sectional survey in Chittoor District of Andhra Pradesh, India
Sirshendu Chaudhuri1, Jayanthi Tarugu2, Kiranmayi Koni2, Kodakinti Udayasree2, Kurugundla Hema2
1 Indian Institute of Public Health, Hyderabad, Telangana, India
2 Apollo College of Nursing, Chittoor, Andhra Pradesh, India
Correspondence Address:
Dr. Sirshendu Chaudhuri
Indian Institute of Public Health, Hyderabad, Telangana
India
 Source of Support: None, Conflict of Interest: None  | Check |
DOI: 10.4103/cmi.cmi_95_21
|
|
|
Background: Vaccination against COVID-19 among people living with HIV (PLWH) infection is crucial. At present, evidence lacks to strategize vaccinating the hesitant PLWH. This study has estimated the proportion of PLWH vaccinated till October 2021, enumerated the various adverse events following vaccination, and identified the enabling and constraining factors associated with vaccination. Methods: A cross-sectional survey was conducted among PLWH by the snowball sampling in the Chittoor district of Andhra Pradesh, India. Data were analyzed using the descriptive statistics and qualitative analyses. Results: Two-hundred and forty-seven PLWH responded, out of which 52 (20.7%) were yet to be vaccinated. Seventy-five (30%) participants reported having adverse events, out of which five (7%) had pain at the injection site, and 72 (96%) had systemic reactions. Fever (n = 51, 68%), dizziness (n = 23, 31%), and joint pain (n = 23, 31%) were the major systemic reactions. Among the vaccinated, motivation by the health-care workers and village volunteers were the major enabling factors. On the contrary, uncertainty about the vaccine effects, negative feedback from the health-care workers, and lack of self-motivation were the important constraining factors in taking the vaccines. Conclusion: Some PLWH are still hesitant to take the vaccine. Evidence generation, coupled with community mobilization, is required to upthrust the vaccination campaign in achieving the herd immunity against COVID-19.
|
|
|
|
| [FULL TEXT] [PDF]* |
|
 |
|
